Cargando…
Modulation of CYP1A1 and CYP1A2 Hepatic Enzymes after Oral Administration of Chios Mastic Gum to Male Wistar Rats
Chios mastic gum (CMG), a resin derived from Pistacia lentiscus var. chia, is known since ancient times for its pharmacological activities. CYP1A1 and CYP1A2 enzymes are among the most involved in the biotransformation of chemicals and the metabolic activation of pro-carcinogens. Previous studies re...
Autores principales: | Katsanou, Efrosini S., Kyriakopoulou, Katerina, Emmanouil, Christina, Fokialakis, Nikolas, Skaltsounis, Alexios-Leandros, Machera, Kyriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065013/ https://www.ncbi.nlm.nih.gov/pubmed/24950217 http://dx.doi.org/10.1371/journal.pone.0100190 |
Ejemplares similares
-
Effects of Chios mastic gum on cardiometabolic risk factors
por: Papazafiropoulou, Athanasia K
Publicado: (2022) -
Overview of Chios Mastic Gum (Pistacia lentiscus) Effects on Human Health
por: Soulaidopoulos, Stergios, et al.
Publicado: (2022) -
Anti-inflammatory activity of Chios mastic gum is associated with inhibition of TNF-alpha induced oxidative stress
por: Triantafyllou, Angelike, et al.
Publicado: (2011) -
Chios Mastic Gum Consumption Has a Protective Effect on Ovariectomy-Induced Bone Loss in Rats
por: Pepe, Angeliki Eirini, et al.
Publicado: (2021) -
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future
por: Ottria, Roberta, et al.
Publicado: (2023)